We are live on
!
Find out more
Acadia Pharmaceuticals
ACAD
ACAD
155 hedge funds and large institutions have $2.08B invested in Acadia Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 48 increasing their positions, 54 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,549% more call options, than puts
Call options by funds: $360M | Put options by funds: $21.9M
62% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 21
38% more funds holding in top 10
Funds holding in top 10: 8 → 11 (+3)
9% more funds holding
Funds holding: 142 → 155 (+13)
5% less capital invested
Capital invested by funds: $2.18B → $2.08B (-$102M)
11% less repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 54
Holders
155
Holders Change
+13
Holders Change %
+9.15%
% of All Funds
4.5%
Holding in Top 10
11
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+37.5%
% of All Funds
0.32%
New
34
Increased
48
Reduced
54
Closed
21
Calls
$360M
Puts
$21.9M
Net Calls
+$338M
Net Calls Change
-$8.22M
Top Buyers
Top Sellers
| 1 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
-$23.9M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$20.4M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$16.9M |
| 4 |
PA
Perceptive Advisors
New York
|
-$16.8M |
| 5 |
Alkeon Capital Management
New York
|
-$16.5M |
